BFLY vs PODD
BFLY: Butterfly Network provides portable, semiconductor-based ultrasound technology to make medical imaging more accessible and affordable globally. PODD: Insulet provides the Omnipod system, a revolutionary tubeless, wearable insulin pump platform that simplifies diabetes management through automated insulin delivery.
Side-by-side fundamentals
| Metric | BFLY | PODD | Edge |
|---|---|---|---|
| Price as of 2026-08-07 close | $8.83 | $141.17 | |
| Market cap as of 2026-08-10 | $2.4B | $9.8B | |
| P/E as of 2026-08-10 | n/a | 26.08 | |
| PEG as of 2026-08-10 | -5.48 | 1.41 | BFLY lower |
| Net margin as of 2026-08-10 | -73.7% | +12.3% | PODD higher |
| Gross margin as of 2026-08-10 | +49.2% | +71.1% | PODD higher |
| Operating margin as of 2026-08-10 | -79.5% | +16.9% | PODD higher |
| ROE as of 2026-08-10 | -36.8% | +17.4% | PODD higher |
| ROA as of 2026-08-10 | -25.6% | +7.5% | PODD higher |
| Debt / equity as of 2026-08-10 | 0.00 | 0.63 | BFLY lower |
| Revenue growth (YoY) as of 2026-08-10 | +20.2% | +29.4% | PODD higher |
| Revenue CAGR (3y) SEC XBRL | +10.0% | +27.5% | PODD higher |
| Dividend streak (yrs) SEC XBRL | 0 | n/a | |
| Beta as of 2026-08-10 | 2.11 | 1.07 | |
| 1-year return as of 2026-08-07 close | +535.3% | -53.5% | BFLY higher |
Fundamentals: market data, as of 2026-08-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-08-07.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & market data, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.